Interestingly, RGS3 has been suggested to negatively regulate MEK/ERK signaling, and HOXD-AS1 is known to reduce RGS3 expression, which can block HCC cell apoptosis and promote proliferation through activation of MEK/ERK signaling (Lu et al., 2017). Here, MAP2K7 is linked to hepatocellular carcinoma.